We are excited to announce that Singota Solutions‘ (Bloomington, Indiana CDMO specializing in aseptic filling, drug development, formulation development, and supply chain management) Vice President of R&D and Operations, Mihaela Simianu, is being prominently featured on the highly regarded industry podcast “Molecule to Market.” In this episode, titled “Becoming…a world-class scientific leader,” host Raman Sehgal takes listeners on an in-depth journey through the intricate landscape of the global drug development sector, highlighting Mihaela’s distinguished career and impactful contributions.
During the podcast, Mihaela shares her unique journey into the biopharmaceutical industry, inspired by her physician parents in Romania. She recounts her 17-year tenure at Eli Lilly, where she gained invaluable experience in drug development and commercialization, ultimately deciding to transition to Amgen. Mihaela discusses her motivations for moving to the CDMO (Contract Development and Manufacturing Organization) side after 25 years on the drug sponsor-side, and what it’s like to be part of a small, agile CDMO like Singota Solutions that supports multiple sponsors to deliver essential therapies to patients.
Mihaela’s conversation covers a range of compelling topics, including the rapid and complex nature of her work at Singota Solutions, the critical advisory and execution roles that CDMO partners play, and the unique challenges and opportunities within the biopharmaceutical supply chain. Her extensive expertise in integrating raw material suppliers, facilities, and engineering equipment into pharmaceutical systems is evident as she shares her experiences in modern product development, quality, and manufacturing systems.
Dr. Simianu’s participation in “Molecule to Market” underscores her role as a transformational leader in the biopharmaceutical industry, and highlights her esteemed position as VP of R&D and Operations at Singota Solutions. We invite you to listen to this enlightening episode to gain a deeper understanding of her extraordinary career, and the vital importance of the global life science outsourcing space.
This feature on “Molecule to Market” not only highlights Mihaela Simianu’s remarkable contributions, but also shines a well-deserved spotlight on Singota Solutions. As a forward-thinking CDMO, Singota Solutions is dedicated to supporting the global biopharmaceutical industry with innovative solutions and exceptional service. Mihaela’s insights and leadership exemplify the company’s commitment to advancing drug development and commercialization processes. This exciting opportunity to showcase Singota Solutions on such a prestigious platform underscores our role in driving the future of personalized medicine and public health. We are proud to be at the forefront of life sciences outsourcing, and we look forward to continuing to make a significant impact in the industry.
Listen to the Full Episode Here: